Rabbit Anti-Human ACTA2 pAb
-
Product Number
PA4709
-
Alias
AAT6, ACTSA, MYMY5, ACTA2, actin
-
Specifications
- 50ul
- 100ul
Product Description
| Alias | AAT6, ACTSA, MYMY5, ACTA2, actin |
| Catalog Number | PA4709 |
| Molecular Name | ACTA2 |
| Host | Rabbit |
| Size | 50ul, 100ul |
| Clonity | Polyclonal |
| Purification | Affinity Purification |
| Formulation | Supply in PBS with 0.02% sodium azide, 50% glycerol, pH 7.4. |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to a.a. 1-124 of human alpha smooth muscle actin (NP_001135417.1). |
| Application | WB, IHC, IF |
| Storage Condition | Store the product under sterile conditions after opening at -20℃. Avoid freeze-thaw cycles. |
| Shipping Condition | Shipped on ice packs. |
| Product Declaration | 本产品仅用于研究用途(RUO)。不能用于诊断或直接用于人体实验。 |
| Product Full Name | Rabbit Anti-Human ACTA2 Polyclonal Antibody |
FAQ
-
Q1- ACTA2蛋白的生物学功能？
ACTA2（α-平滑肌肌动蛋白）是血管平滑肌细胞标志物。
-
Q2- 是否适用于血管组织的免疫组化（IHC）？
是的，推荐主动脉或小动脉石蜡切片，需柠檬酸修复（pH 6.0），抗体稀释1:200。
-
Q3- 抗体是否与骨骼肌或心肌α-肌动蛋白（ACTA1/ACTC1）交叉反应？
无交叉反应，已通过心肌和骨骼肌组织验证特异性，WB预期条带约42 kDa。
-
Q4- 如何保存抗体以维持稳定性？
分装后-80℃保存（含50%甘油），避免反复冻融；工作液4℃稳定2周。
-
Q5- 是否提供TAAD患者样本的验证数据？
是的，提供患者主动脉组织ACTA2突变导致的异常聚集IHC结果。
- Protein Platform
- Protein Expression Services
- Protein Modification & Detection Services
- Protein Interaction Services
- Protein Purification Service
- Antibody Discovery Platform
- VHH Antibody Platform
- Phage Display Platform
- Antibody Humanization Platform
- Single B Cell Screening Platform
- Antibody Expression & Validation Platform
- Peptide Library Platform
- Custom Antibody Platform
- Innovative Drug Discovery Platform
- Product Center
- Proteins
- Antibodies
- Raw Materials Reagents
- Small Molecule Reagents
- Peptide Products
- Nanoparticle Products
- Contact Us
- Phone：400-621-6806
- Mobile：13110936064（WeC
- E-mail：[email protected]
- Address：Room 108, Building 10, No. 6 Hechang Road, Wuqing Development Zone, Tianjin City
-
WeChat
-
Service Account
-
400-621-6806 -
3599163699 -
Monday to Friday 9:00-18:00 -
-
0
-
